How is Daratumumab and Hyaluronidase-FIHJ dosed?
The medication is available in the form of a solution for injection. The dosage should be determined by a healthcare professional.
How is Daratumumab and Hyaluronidase-FIHJ administered?
Daratumumab and hyaluronidase-FIHJ subcutaneous route is administered through an injection under the skin. It is usually given by a healthcare professional in a medical setting, such as a doctor's office, clinic, or hospital. The injection is given slowly and the full dose should take about 3 to 5 minutes to administer. It is important to follow your doctor's instructions carefully for the dosage and frequency of administration.
What are common precautions when taking Daratumumab and Hyaluronidase-FIHJ?
Common precautions when taking daratumumab and hyaluronidase-FIHJ subcutaneous route include:
- Avoiding contact sports or situations where bruising or injury could occur.
- Being cautious when using sharp objects, such as safety razors or nail cutters, to prevent cutting oneself.
- Informing any doctor who treats you that you are receiving this medicine, as it may affect the results of certain medical tests (e.g., tests to determine your blood type). These effects may last up to 6 months after your last dose.
- Telling your doctor or other health professional before receiving a blood transfusion.
It is important to consult with a healthcare professional for personalized advice and accurate information.